These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33912826)

  • 1. Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant.
    Russell GC; Haig DM; Dagleish MP; Todd H; Percival A; Grant DM; Thomson J; Karagianni AE; Benavides J
    Vaccine X; 2021 Aug; 8():100090. PubMed ID: 33912826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen
    Lankester F; Lugelo A; Werling D; Mnyambwa N; Keyyu J; Kazwala R; Grant D; Smith S; Parameswaran N; Cleaveland S; Russell G; Haig D
    Vet Microbiol; 2016 Nov; 195():144-153. PubMed ID: 27771060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.
    Parameswaran N; Russell GC; Bartley K; Grant DM; Deane D; Todd H; Dagleish MP; Haig DM
    Vet Res; 2014 May; 45(1):59. PubMed ID: 24886334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever.
    Russell GC; Benavides J; Grant D; Todd H; Deane D; Percival A; Thomson J; Connelly M; Haig DM
    Vet Res; 2012 Jun; 43(1):51. PubMed ID: 22686373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.
    Lankester F; Russell GC; Lugelo A; Ndabigaye A; Mnyambwa N; Keyyu J; Kazwala R; Grant D; Percival A; Deane D; Haig DM; Cleaveland S
    Vaccine; 2016 Feb; 34(6):831-8. PubMed ID: 26706270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of Glycoprotein B in Alcelaphine Herpesvirus 1 by Its Ovine Herpesvirus 2 Homolog : Implications in Vaccine Development for Sheep-Associated Malignant Catarrhal Fever.
    Cunha CW; Taus NS; Dewals BG; Vanderplasschen A; Knowles DP; Li H
    mSphere; 2016; 1(4):. PubMed ID: 27504498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant catarrhal fever in American bison (Bison bison) experimentally infected with alcelaphine herpesvirus 2.
    Taus NS; O'Toole D; Herndon DR; Cunha CW; Warg JV; Seal BS; Brooking A; Li H
    Vet Microbiol; 2014 Aug; 172(1-2):318-22. PubMed ID: 24803260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever.
    Haig DM; Grant D; Deane D; Campbell I; Thomson J; Jepson C; Buxton D; Russell GC
    Vaccine; 2008 Aug; 26(35):4461-8. PubMed ID: 18601965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral semaphorin inhibits dendritic cell phagocytosis and migration but is not essential for gammaherpesvirus-induced lymphoproliferation in malignant catarrhal fever.
    Myster F; Palmeira L; Sorel O; Bouillenne F; DePauw E; Schwartz-Cornil I; Vanderplasschen A; Dewals BG
    J Virol; 2015 Apr; 89(7):3630-47. PubMed ID: 25589653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised vaccine field trial in Kenya demonstrates protection against wildebeest-associated malignant catarrhal fever in cattle.
    Cook E; Russell G; Grant D; Mutisya C; Omoto L; Dobson E; Lankester F; Nene V
    Vaccine; 2019 Sep; 37(40):5946-5953. PubMed ID: 31473000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of the genome of Alcelaphine herpesvirus 1 as an infectious and pathogenic bacterial artificial chromosome.
    Dewals B; Boudry C; Gillet L; Markine-Goriaynoff N; de Leval L; Haig DM; Vanderplasschen A
    J Gen Virol; 2006 Mar; 87(Pt 3):509-517. PubMed ID: 16476972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcelaphine herpesvirus 1 glycoprotein B: recombinant expression and antibody recognition.
    Dry I; Todd H; Deane D; Percival A; Mclean K; Inglis NF; Manson ED; Haig DM; Nayuni S; Hutt-Fletcher LM; Grant DM; Bartley K; Stewart JP; Russell GC
    Arch Virol; 2016 Mar; 161(3):613-9. PubMed ID: 26650040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small RNA deep sequencing identifies viral microRNAs during malignant catarrhal fever induced by alcelaphine herpesvirus 1.
    Sorel O; Tuddenham L; Myster F; Palmeira L; Kerkhofs P; Pfeffer S; Vanderplasschen A; Dewals BG
    J Gen Virol; 2015 Nov; 96(11):3360-3372. PubMed ID: 26329753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
    Gonczol E; Plotkin S
    Expert Opin Biol Ther; 2001 May; 1(3):401-12. PubMed ID: 11727514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I.
    Beer M; Hehnen HR; Wolfmeyer A; Poll G; Kaaden OR; Wolf G
    Vet Microbiol; 2000 Nov; 77(1-2):195-208. PubMed ID: 11042413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcelaphine herpesvirus 1 genes A7 and A8 regulate viral spread and are essential for malignant catarrhal fever.
    Myster F; Gong MJ; Javaux J; Suárez NM; Wilkie GS; Connelley T; Vanderplasschen A; Davison AJ; Dewals BG
    PLoS Pathog; 2020 Mar; 16(3):e1008405. PubMed ID: 32176737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunisation of cattle against Babesia bovis combining a multi-epitope modified vaccinia Ankara virus and a recombinant protein induce strong Th1 cell responses but fails to trigger neutralising antibodies required for protection.
    Jaramillo Ortiz JM; Paoletta MS; Gravisaco MJ; López Arias LS; Montenegro VN; de la Fournière SAM; Valenzano MN; Guillemi EC; Valentini B; Echaide I; Farber MD; Wilkowsky SE
    Ticks Tick Borne Dis; 2019 Oct; 10(6):101270. PubMed ID: 31445874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of malignant catarrhal fever, with an emphasis on ovine herpesvirus 2.
    O'Toole D; Li H
    Vet Pathol; 2014 Mar; 51(2):437-52. PubMed ID: 24503439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine Adjuvants in Fish Vaccines Make a Difference: Comparing Three Adjuvants (Montanide ISA763A Oil, CpG/Poly I:C Combo and VHSV Glycoprotein) Alone or in Combination Formulated with an Inactivated Whole Salmonid Alphavirus Antigen.
    Thim HL; Villoing S; McLoughlin M; Christie KE; Grove S; Frost P; Jørgensen JB
    Vaccines (Basel); 2014 Mar; 2(2):228-51. PubMed ID: 26344619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.